Results 151 to 160 of about 23,757 (183)
Prior Dual Antiplatelet Therapy and Mortality After Intracerebral Hemorrhage: A Danish Nationwide Cohort Study. [PDF]
J Am Heart AssocOvesen C +7 more
europepmc +1 more source
Quality control of B-lines analysis in stress Echo 2020 [PDF]
, 2018 et al,, Perez, Julio E
core +1 more source
Effect of Dipyridamole on Experimental Autoimmune Uveitis: Reprogrammed Immune Cell Landscape and Reduced Th17 Pathogenicity. [PDF]
Invest Ophthalmol Vis SciChen B +9 more
europepmc +1 more source
Unveiling key genes for intervertebral disc degeneration prediction and potential drug discovery. [PDF]
Sci RepLi TJ, Wang YS, Lan BB, Liu JW.
europepmc +1 more source
Topical Application of Dipyridamole and Roflumilast Combination Nanoparticles Loaded Nanoemulgel for the Treatment of Psoriasis in Rats. [PDF]
Int J NanomedicineMaded ZK +7 more
europepmc +1 more source
Attenuation of HIV-specific T cell responses Among people with HIV on ART following dipyridamole treatment. [PDF]
J Leukoc BiolMorris BC +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Pharmacology and Therapeutics, 1982
The kinetics of the antiplatelet drug dipyridamole were studied in six normal subjects (three men and three women) who were ages 22 to 34 yr old. Each received 20 mg IV and four also took a 50-mg oral dose. Blood samples were collected after each dose for a period of 3 days and concentrations of dipyridamole were measured by a sensitive and specific ...
C, Mahony +3 more
openaire +2 more sources
The kinetics of the antiplatelet drug dipyridamole were studied in six normal subjects (three men and three women) who were ages 22 to 34 yr old. Each received 20 mg IV and four also took a 50-mg oral dose. Blood samples were collected after each dose for a period of 3 days and concentrations of dipyridamole were measured by a sensitive and specific ...
C, Mahony +3 more
openaire +2 more sources
Echocardiography, 1992
Intravenous dipyridamole is a potent coronary vasodilator that has been extensively investigated over the past several years in the noninvasive assessment of patients with suspected coronary artery disease when exercise cannot be performed or is suboptimal.
R, Castello, A J, Labovitz
openaire +2 more sources
Intravenous dipyridamole is a potent coronary vasodilator that has been extensively investigated over the past several years in the noninvasive assessment of patients with suspected coronary artery disease when exercise cannot be performed or is suboptimal.
R, Castello, A J, Labovitz
openaire +2 more sources